ILLUMINA
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · California, United States · 5K - 10K Employees
View Company Info for Free
Overview
Headquarters
5200 Illumina Way, San Diego, California...Phone Number
(858) 202-4500Website
www.illumina.comRevenue
$4.4 BillionStock Symbol
ILMNIndustry
ZI Rank: 2
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
14
1
2
2
2
2
About ILLUMINA
Illumina, Inc. offers sequencing- and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services; and Galleri, a multi-cancer early detection test. In addition, the company is developing solutions to help accelerate cancer diagnoses, blood-based detection for minimal residual disease, and other post-diagnostic applications. The company serves genomic research centers, academic institutions, government laboratories,Read more
ILLUMINA Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is ILLUMINA your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if ILLUMINA has recently received funding, and reach out quickly before it becomes old news!
Click to see if ILLUMINA had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if ILLUMINA is spiking on competitors!
ILLUMINA, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on ILLUMINA recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at ILLUMINA
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once ILLUMINA has new funding data
Product Launch: Get notified when ILLUMINA launches new products
Recommended Actions
Reach out to Masked Content who joined ILLUMINA as Masked Content
Find 2 more new buyers
Compare Similar Companies to ILLUMINA
Compare insights from companies similar to ILLUMINA, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
ILLUMINA is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
ILLUMINA is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about ILLUMINA.
ILLUMINA financials insights
Gather financial insights about ILLUMINA, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2000
Stock Offering
$96M
2023
Debt
$750M
ILLUMINA Tech Stack
A closer look at the technologies used by ILLUMINA
Most Recent Scoops
Open Position
Open Position
Open Position
Open Position
Open Position
ILLUMINA News & Media
Illumina Reports Financial Results for Second Quarter of Fiscal Year 2026
SAN DIEGO, July 30, 2026 /PRNewswire/ -- Illumina, Inc. (Nasdaq: ILMN) ("Illumina" or the "company") today announced its financial results for the second quarter of fiscal year 2026. Second quarter 2026 results Revenue of $1.16 billion for Q2 2026, up 9.5% from Q2 2025 and up 8.1%...Illumina expands Billion Cell Atlas program with new AI drug developers
Partners will use unprecedented data scale to advance more precise medicines to approval SAN DIEGO, July 16, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that the Billion Cell Atlas alliance has added three new member companies, including AI-native drug developer...People moves: Julie Coletti joins Illumina as its new CLO - | Governance Intelligence
Illumina has named Julie Coletti as its new chief legal officer, effective from August 3.Illumina to Announce Second Quarter 2026 Financial Results on Thursday, July 30, 2026
SAN DIEGO, July 9, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) announced today that it will issue results for the second quarter 2026 following the close of market on Thursday, July 30, 2026. On the same day, at 1:30 pm Pacific Time (4:30 pm Eastern Time) Jacob Thaysen, PhD, Chief...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding ILLUMINA
Sign Up For FreeTo access detailed company insights
Illumina, Inc. offers sequencing- and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library prepar... Read More
